Contact
Please use this form to send email to PR contact of this press release:
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
TO: